NEW YORK, Sept. 16, 2013 /PRNewswire/ -- Pomerantz Grossman Hufford Dahlstrom & Gross LLP is investigating claims on behalf of investors of Cornerstone Therapeutics, Inc. ("Cornerstone" or the "Company") (NASDAQ: CRTX) (ISIN: US21924P1030) (CUSIP: 21924P103) concerning the......
More...
